Chemical Compound
interleukin-1beta (163-171)
CAS Registry Number
106021-96-9
Primary Record
interleukin-1beta (163-171)
- In stock
- 3,609 g
- Purity
- 99.8 %
- CAS
- 106021-96-9
Compound Identifiers & Properties
- CAS
- 106021-96-9
- PubChem CID
- 123872
- SMILES
- CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N
- Canonical SMILES
- CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
Names & Synonyms
- interleukin-1beta (163-171)
- IL-1beta (163-171)
- AC1L3XGG
- RefChem:148440
- 106021-96-9
- Interleukin 1-beta (163-171)
- DTXSID801044207
- SCHEMBL6856783
- NIXBZDOQHRZFDR-OEWCNXHOSA-N
- Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys
- C39H64N12O19
- CID123872
- |A-Interleukin I (163-171), human
- -Interleukin I (163-171), human
- BAT-016298
- Interleukin 1beta(163-171)[human]
- C39-H64-N12-O19
- H-Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-OH
- NCGC00167209-01
- beta-Interleukin I (163-171), human
- FI109999
- Interleukin-1|A Fragment 163-171 human
- Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-OH
- HY-113893
- Interleukin-1beta Fragment 163-171 human
- J437.500I
- CS-0063273
- A15426
- IL-1beta (163-171) (human) trifluoroacetate salt
- 4-(TRANS-4-PROPYLCYCLOHEXYL)-2-FLUOROBENZONITRILE
- (2S)-6-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]hexanoic acid
- L-valyl-L-glutaminylglycyl-L-glutamyl-L-glutamyl-L-seryl-L-asparaginyl-L-aspartyl-L-lysine
- Interleukin-1beta Fragment 163-171 human, >=97% (HPLC), synthetic
- (2S)-6-AMINO-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-AMINO-3-METHYLBUTANAMIDO]-4-CARBAMOYLBUTANAMIDO]ACETAMIDO}-4-CARBOXYBUTANAMIDO]-4-CARBOXYBUTANAMIDO]-3-HYDROXYPROPANAMIDO]-3-CARBAMOYLPROPANAMIDO]-3-CARBOXYPROPANAMIDO]HEXANOIC ACID
- (2S)-6-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-4-hydroxy-4-oxobutanoyl]amino]hexanoic acid
- L-Lysine, N2-(N-(N2-(N-(N-(N-(N-(N2-L-valyl-L-glutaminyl)glycyl)-L-alph-glutamyl)-L-alpha-glutamyl)-L-seryl)-L-asparaginyl)-L-alpha-aspartyl)-
- L-Lysine,l-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-l-a-aspartyl-